rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2011-1-28
|
pubmed:abstractText |
Despite the clinical similarities triple-negative and basal-like breast cancer are not synonymous. Indeed, not all basal-like cancers are negative for estrogen receptor, progesterone receptor and HER2 expression while triple-negative also encompasses other cancer types. P53 protein appears heterogeneously expressed in triple-negative breast cancers, suggesting that it may be associated with specific biological subgroups with a different outcome.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/HER2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Protein p53
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1465-3621
|
pubmed:author |
pubmed-author:AlbertiSaverioS,
pubmed-author:AmbrogiFedericoF,
pubmed-author:BiganzoliEliaE,
pubmed-author:BoracchiPatriziaP,
pubmed-author:CoradiniDanilaD,
pubmed-author:DemicheliRomanoR,
pubmed-author:EllisIan OIO,
pubmed-author:GaribaldiJonhatan MJM,
pubmed-author:GreenAndrew RAR,
pubmed-author:LisboaPauloP,
pubmed-author:NenciItaloI,
pubmed-author:PedrialiMassimoM,
pubmed-author:PiantelliMauroM,
pubmed-author:QuerzoliPatriziaP,
pubmed-author:SoriaDanieleD
|
pubmed:issnType |
Electronic
|
pubmed:volume |
41
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
172-9
|
pubmed:meshHeading |
pubmed-meshheading:21199790-Breast Neoplasms,
pubmed-meshheading:21199790-Diagnosis, Differential,
pubmed-meshheading:21199790-Female,
pubmed-meshheading:21199790-Humans,
pubmed-meshheading:21199790-Neoplasms, Basal Cell,
pubmed-meshheading:21199790-Prognosis,
pubmed-meshheading:21199790-Receptor, erbB-2,
pubmed-meshheading:21199790-Receptors, Estrogen,
pubmed-meshheading:21199790-Receptors, Progesterone,
pubmed-meshheading:21199790-Survival Analysis,
pubmed-meshheading:21199790-Tumor Markers, Biological,
pubmed-meshheading:21199790-Tumor Suppressor Protein p53
|
pubmed:year |
2011
|
pubmed:articleTitle |
p53 status identifies two subgroups of triple-negative breast cancers with distinct biological features.
|
pubmed:affiliation |
Department of Work Medicine Clinica del Lavoro L. Devoto, Section Department of Medical Statistics and Biometry G.A. Maccacaro, University of Milan, Via Vanzetti 5, 20133 Milan, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|